COVID-19 opened the eyes of many cardiology researchers that infections may promote inflammation in atherosclerotic plaques, leading to cardiac events.

Creating these complex structures with 3D printing alone has never been possible—until now. 

What’s more, the model proved beneficial in a large, diverse cohort that included women with benign breast disease and BRCA mutations.

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

Although the predictive power of radiomics has been touted as a tool that could improve patient outcomes, the method has a long way to go before it can be reliably introduced into real-world clinical environments.

Targeting immune cells that play a key role in the development of atrial fibrillation could give cardiologists a new way to treat the disease.

The randomized, double-blinded phase 3 study revealed gadopiclenol to be noninferior to gadobutrol for all qualitative visualization parameters as rated by all blinded readers involved in the trial.

Researchers at the National Institute of Standards and Technology (NIST) are working on developing measurements that will provide better insight into soft tissue properties visualized on portable MRI images.